This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Volume 56, Issue Suppl_1 , Page ATP311-ATP311, February 1, 2025. Introduction:Immune Checkpoint Inhibitors (ICIs) used for treatment of malignancies might promote atherosclerosis and increase the risk of ischemic stroke (IS). We collected demographics and stroke characteristics. range 27-386) vs. ICI 337.5
Stroke, Volume 56, Issue Suppl_1 , Page ATP324-ATP324, February 1, 2025. Background and Purpose:Antiphospholipid antibody syndrome (APS) is a rare cause of cerebral infarction, but the effect of antiphospholipid antibodies (aPL) on the acute phase of ischemic stroke in each stroke subtypes is still unclear, especially in the elderly patients.
Stroke, Volume 56, Issue Suppl_1 , Page AWP276-AWP276, February 1, 2025. Methods:In this observational registry study, we reviewed patients from our comprehensive stroke center who underwent DSA from January 2013 to December 2023. Background and Objectives:Vertebral artery hypoplasia (VAH) is a common anatomical variation.
Stroke-volume:50 ml. See "Mechanisms of acute coronary syndromes related to atherosclerosis".) Left ventricular end-diastolic volume: 99 ml. Left ventricular systolic volume: 49 ml. Left ventricular ejection fraction:50 %. Wall motion, wall thickening: No wall motion abnormality detected. Normal wall thickness.
3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heart attack or myocardial infarction (MI), stroke, and cardiovascular (CV) death.4 1,6 Until recently atherosclerosis has been thought of as the result of passive lipid accumulation in the vessel wall. 4 In the U.S.
Stroke, Volume 54, Issue 12 , Page 3002-3011, December 1, 2023. BACKGROUND:There is limited information on the delivery of acute stroke therapies and secondary preventive measures and clinical outcomes over time in young adults with acute ischemic stroke. 56.2%), and statins for large artery atherosclerosis (76.1%–95.3%)
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIntracranial atherosclerosis (ICAS) is a leading global cause of stroke. 1‐year rate of stroke and death in stented patients [5]. The role of intracranial stenting in ICAS remains uncertain.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP24-AWMP24, February 1, 2025. Low HRV (L-HRV) is linked to an increased risk for ischemic stroke. White Matter Hyperintensities (WMH) is a measure of cerebral small vessel disease (cSVD) which is associated with lacunar ischemic stroke.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP79-ATMP79, February 1, 2024. These microhemorrhages are a possible risk factor for ICH.Methods:A cohort of ARIC (Atherosclerosis Risk in Communities) participants underwent 3T MRI at visit 5 (2011-2013). CMBs were assessed using a T2* gradient echo.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content